 | • レポートコード：QFJ1-5430 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（納期：3日） • 産業分類：新技術 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、新型コロナウイルス感染症用中国製医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（Xuebijing注射、Lianhua Qingwen、その他）、用途別市場規模（軽度症状患者、重篤患者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・新型コロナウイルス感染症用中国製医薬品の市場動向 ・企業の競争状況、市場シェア ・新型コロナウイルス感染症用中国製医薬品の種類別市場規模と予測2016-2027（Xuebijing注射、Lianhua Qingwen、その他） ・新型コロナウイルス感染症用中国製医薬品の用途別市場規模と予測2016-2027（軽度症状患者、重篤患者） ・新型コロナウイルス感染症用中国製医薬品の北米市場規模2016-2027（アメリカ、カナダ） ・新型コロナウイルス感染症用中国製医薬品の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・新型コロナウイルス感染症用中国製医薬品のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・新型コロナウイルス感染症用中国製医薬品の中南米市場規模2016-2027（メキシコ、ブラジル） ・新型コロナウイルス感染症用中国製医薬品の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Tianjin Chase Sun Pharmaceutical Co., Ltd.、Shijiazhuang Yiling Pharmaceutical Co., Ltd.） ・結論 |
In 2021, the global Chinese Materia Medica for COVID-19 market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global Chinese Materia Medica for COVID-19 status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Chinese Materia Medica for COVID-19 development in North America, Europe, Japan, China, Southeast Asia, India, etc.
Global Chinese Materia Medica for COVID-19 Scope and Market Size
Chinese Materia Medica for COVID-19 market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Chinese Materia Medica for COVID-19 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Xuebijing Injection
Lianhua Qingwen
Others
Segment by Application
Mild Symptom Patient
Critically Ill Patient
By Region
North America
Europe
Japan
China
Southeast Asia
India
By Company
Tianjin Chase Sun Pharmaceutical Co., Ltd.
Shijiazhuang Yiling Pharmaceutical Co., Ltd.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chinese Materia Medica for COVID-19 Market Size Growth Rate by Type (2021-2027)
1.2.2 Xuebijing Injection
1.2.3 Lianhua Qingwen
1.2.4 Others
1.3 Market by Application
1.3.1 Global Chinese Materia Medica for COVID-19 Market Share by Application (2021-2027)
1.3.2 Mild Symptom Patient
1.3.3 Critically Ill Patient
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Chinese Materia Medica for COVID-19 Market Size
2.2 Chinese Materia Medica for COVID-19 Market Size by Regions
2.2.1 Chinese Materia Medica for COVID-19 Growth Rate by Regions (2021-2027)
2.2.2 Chinese Materia Medica for COVID-19 Market Share by Regions (2021-2027)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases
3 Key Players
3.1 Chinese Materia Medica for COVID-19 Revenue by Players (2020-2021)
3.2 Chinese Materia Medica for COVID-19 Key Players Headquaters and Area Served
3.3 Key Players Chinese Materia Medica for COVID-19 Product/Solution/Service
3.4 Date of Enter into Chinese Materia Medica for COVID-19 Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown by Type and by Application
4.1 Global Chinese Materia Medica for COVID-19 Market Size by Type (2021-2027)
4.2 Global Chinese Materia Medica for COVID-19 Market Size by Application (2021-2027)
5 North America
5.1 North America Chinese Materia Medica for COVID-19 Market Forecast (2021-2027)
5.2 Chinese Materia Medica for COVID-19 Key Players in North America
5.3 North America Chinese Materia Medica for COVID-19 Market Size by Type
5.4 North America Chinese Materia Medica for COVID-19 Market Size by Application
6.4.4 Canada
6 Europe
6.1 Europe Chinese Materia Medica for COVID-19 Market Forecast (2021-2027)
6.2 Chinese Materia Medica for COVID-19 Key Players in Europe
6.3 Europe Chinese Materia Medica for COVID-19 Market Size by Type
6.4 Europe Chinese Materia Medica for COVID-19 Market Size by Application
7 Japan
7.1 Japan Chinese Materia Medica for COVID-19 Market Forecast (2021-2027)
7.2 Chinese Materia Medica for COVID-19 Key Players in Europe
7.3 Japan Chinese Materia Medica for COVID-19 Market Size by Type
7.4 Japan Chinese Materia Medica for COVID-19 Market Size by Application
8 Rest of World
8.1 China
8.1.1 China Chinese Materia Medica for COVID-19 Market Analysis
8.1.2 Key Players in China
8.2 Southeast Asia
8.2.1 Southeast Asia Chinese Materia Medica for COVID-19 Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Chinese Materia Medica for COVID-19 Market Analysis
8.3.2 Key Players in India
9 International Player Profiles
9.1 Tianjin Chase Sun Pharmaceutical Co., Ltd.
9.1.1 Tianjin Chase Sun Pharmaceutical Co., Ltd. Company Details
9.1.2 Tianjin Chase Sun Pharmaceutical Co., Ltd. Description and Business Overview
9.1.3 Tianjin Chase Sun Pharmaceutical Co., Ltd. Chinese Materia Medica for COVID-19 Introduction
9.1.4 Tianjin Chase Sun Pharmaceutical Co., Ltd. Revenue in Chinese Materia Medica for COVID-19 Business (2020-2021)
9.1.5 Tianjin Chase Sun Pharmaceutical Co., Ltd. Recent Development
9.2 Shijiazhuang Yiling Pharmaceutical Co., Ltd.
9.2.1 Shijiazhuang Yiling Pharmaceutical Co., Ltd. Company Details
9.2.2 Shijiazhuang Yiling Pharmaceutical Co., Ltd. Description and Business Overview
9.2.3 Shijiazhuang Yiling Pharmaceutical Co., Ltd. Chinese Materia Medica for COVID-19 Introduction
9.2.4 Shijiazhuang Yiling Pharmaceutical Co., Ltd. Revenue in Chinese Materia Medica for COVID-19 Business (2020-2021)
9.2.5 Shijiazhuang Yiling Pharmaceutical Co., Ltd. Recent Development
10 Market Dynamics
10.1 Industry Trends
10.2 Market Drives
10.3 Market Challenges
10.4 Market Restraints
11 Key Findings in This Report
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
Table 1. Global Chinese Materia Medica for COVID-19 Market Size Growth Rate by Type (2021-2027) (US$ Million)
Table 2. Key Players of Xuebijing Injection
Table 3. Key Players of Lianhua Qingwen
Table 4. Key Players of Others
Table 5. Global Chinese Materia Medica for COVID-19 Market Size Growth by Application (2021-2027) (US$ Million)
Table 6. Global Chinese Materia Medica for COVID-19 Market Size by Regions (2021-2027) (US$ Million)
Table 7. Global Chinese Materia Medica for COVID-19 Market Share by Regions (2021-2027)
Table 8. Market Top Trends
Table 9. Market Use Cases
Table 10. Global Chinese Materia Medica for COVID-19 Revenue by Players (2020-2021) (US$ Million)
Table 11. Global Chinese Materia Medica for COVID-19 Market Share by Players (2020-2021)
Table 12. Key Players Headquarters and Area Served
Table 13. Key Players Chinese Materia Medica for COVID-19 Product Solution and Service
Table 14. Date of Enter into Chinese Materia Medica for COVID-19 Market
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Chinese Materia Medica for COVID-19 Market Size by Type (2021-2027) (US$ Million)
Table 17. Global Chinese Materia Medica for COVID-19 Market Size Share by Type (2021-2027)
Table 18. Global Chinese Materia Medica for COVID-19 Market Size by Application (2021-2027) (US$ Million)
Table 19. Global Chinese Materia Medica for COVID-19 Market Size Share by Application (2021-2027)
Table 20. North America Key Players Chinese Materia Medica for COVID-19 Revenue (2020-2021) (US$ Million)
Table 21. North America Key Players Chinese Materia Medica for COVID-19 Market Share (2020-2021)
Table 22. North America Chinese Materia Medica for COVID-19 Market Size by Type (2021-2027) (US$ Million)
Table 23. North America Chinese Materia Medica for COVID-19 Market Share by Type (2021-2027)
Table 24. North America Chinese Materia Medica for COVID-19 Market Size by Application (2021-2027) (US$ Million)
Table 25. North America Chinese Materia Medica for COVID-19 Market Share by Application (2021-2027)
Table 26. Europe Key Players Chinese Materia Medica for COVID-19 Revenue (2020-2021) (US$ Million)
Table 27. Europe Key Players Chinese Materia Medica for COVID-19 Market Share (2020-2021)
Table 28. Europe Chinese Materia Medica for COVID-19 Market Size by Type (2021-2027) (US$ Million)
Table 29. Europe Chinese Materia Medica for COVID-19 Market Share by Type (2021-2027)
Table 30. Europe Chinese Materia Medica for COVID-19 Market Size by Application (2021-2027) (US$ Million)
Table 31. Europe Chinese Materia Medica for COVID-19 Market Share by Application (2021-2027)
Table 32. Japan Key Players Chinese Materia Medica for COVID-19 Revenue (2020-2021) (US$ Million)
Table 33. Japan Key Players Chinese Materia Medica for COVID-19 Market Share (2020-2021)
Table 34. Japan Chinese Materia Medica for COVID-19 Market Size by Type (2021-2027) (US$ Million)
Table 35. Japan Chinese Materia Medica for COVID-19 Market Share by Type (2021-2027)
Table 36. Japan Chinese Materia Medica for COVID-19 Market Size by Application (2021-2027) (US$ Million)
Table 37. Japan Chinese Materia Medica for COVID-19 Market Share by Application (2021-2027)
Table 38. Key Players in China
Table 39. Key Players in Southeast Asia
Table 40. Key Players in India
Table 41. Tianjin Chase Sun Pharmaceutical Co., Ltd. Company Details
Table 42. Tianjin Chase Sun Pharmaceutical Co., Ltd. Description and Business Overview
Table 43. Tianjin Chase Sun Pharmaceutical Co., Ltd. Chinese Materia Medica for COVID-19 Product
Table 44. Tianjin Chase Sun Pharmaceutical Co., Ltd. Revenue in Chinese Materia Medica for COVID-19 Business 2020 and 2021
Table 45. Tianjin Chase Sun Pharmaceutical Co., Ltd. Recent Development
Table 46. Shijiazhuang Yiling Pharmaceutical Co., Ltd. Company Details
Table 47. Shijiazhuang Yiling Pharmaceutical Co., Ltd. Description and Business Overview
Table 48. Shijiazhuang Yiling Pharmaceutical Co., Ltd. Chinese Materia Medica for COVID-19 Product
Table 49. Shijiazhuang Yiling Pharmaceutical Co., Ltd. Revenue in Chinese Materia Medica for COVID-19 Business 2020 and 2021
Table 50. Shijiazhuang Yiling Pharmaceutical Co., Ltd. Recent Development
Table 51. Chinese Materia Medica for COVID-19 Market Trends
Table 52. Chinese Materia Medica for COVID-19 Market Drivers
Table 53. Chinese Materia Medica for COVID-19 Market Challenges
Table 54. Chinese Materia Medica for COVID-19 Market Restraints
Table 55. Research Programs/Design for This Report
Table 56. Key Data Information from Secondary Sources
Table 57. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chinese Materia Medica for COVID-19 Market Share by Type in 2021 & 2027
Figure 2. Xuebijing Injection Features
Figure 3. Lianhua Qingwen Features
Figure 4. Others Features
Figure 5. Global Chinese Materia Medica for COVID-19 Market Share by Application in 2021 & 2027
Figure 6. Mild Symptom Patient Case Studies
Figure 7. Critically Ill Patient Case Studies
Figure 8. Chinese Materia Medica for COVID-19 Report Years Considered
Figure 9. Global Chinese Materia Medica for COVID-19 Market Size and Growth Rate (2020-2027) (US$ Million)
Figure 10. Global Chinese Materia Medica for COVID-19 Market Share by Regions (2020-2027)
Figure 11. Global Chinese Materia Medica for COVID-19 Market Share by Players in 2021
Figure 12. Global Chinese Materia Medica for COVID-19 Market Size Market Share by Type (2021-2027)
Figure 13. Global Chinese Materia Medica for COVID-19 Market Size Market Share by Application (2021-2027)
Figure 14. Global Chinese Materia Medica for COVID-19 Revenue Market Share by Application in 2021
Figure 15. North America Chinese Materia Medica for COVID-19 Market Size 2021-2027 (US$ Million)
Figure 16. Europe Chinese Materia Medica for COVID-19 Market Size 2021-2027 (US$ Million)
Figure 17. Japan Chinese Materia Medica for COVID-19 Market Size 2021-2027 (US$ Million)
Figure 18. Chinese Materia Medica for COVID-19 Market Size in China (2021-2027) (US$ Million)
Figure 19. Chinese Materia Medica for COVID-19 Market Size in Southeast Asia (2021-2027) (US$ Million)
Figure 20. Chinese Materia Medica for COVID-19 Market Size in India (2021-2027) (US$ Million)
Figure 21. Bottom-up and Top-down Approaches for This Report
Figure 22. Data Triangulation
Figure 23. Key Executives Interviewed
世界の新型コロナウイルス感染症用従来型漢方薬市場規模・現状・予測（2021年-2027年） At present, the global COVID-19 epidemic is progressing rapidly. Chinese medicine has a long history and plays an indispensable role in the prevention and treatment of various epidemics. During the treatment of COVID-19, the intervention of Chinese medicine has also achieved remarkable results. In 2…- 世界の新型コロナウイルス感染症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Covid-19 Treatments Market The global Covid-19 Treatments market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report mak…
- 世界の新型コロナウイルス感染症用医薬品市場規模・現状・予測（2021年-2027年） In 2021, the global COVID-19 Drugs market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. This report focuses on the global COVID-19 Drugs status, future forecast, growth opportunity, key market, and key players. The stu…
- 世界の新型コロナウイルス感染症ワクチン市場規模・現状・予測（2021年-2027年） In 2021, the global Novel Coronavirus (COVID-19) Vaccine market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. This report focuses on the global Novel Coronavirus (COVID-19) Vaccine status, future forecast, growth oppor…
- 世界の新型コロナウイルス感染症特定抗ウイルス薬市場規模・現状・予測（2021年-2027年） In 2021, the global Specific Antiviral Drugs for COVID-19 market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. This report focuses on the global Specific Antiviral Drugs for COVID-19 status, future forecast, growth opp…